Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
The Lancet, 06/01/09
In primary prevention without previous disease, aspirin is of uncertain net value as the reduction in occlusive events needs to be weighed against any increase in major bleeds. Further trials are in progress.
Today in Over The Counter (OTC)...keeping you current
Receive free subspecialty "5-minute updates" via email
A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding
Clinical Therapeutics, 11/02/09
The management of paracetamol poisoning
Paediatrics and Child Health, 11/09/09
Aspirin use associated with lower colorectal cancer mortality
American Pharmacists Association, 10/14/09
Sponsor
Article Search
Sponsor


See Latest Articles


